Alzecure: Jan Lundberg proposed as board member
Research Note
2024-04-10
11:29
Redeye endorses today’s news that the nomination committee has proposed Jan Lundberg, Eli Lilly's and AstraZeneca's former head of research, as a new board member of Alzecure. We give a short comment.
FT
Fredrik Thor
Disclosures and disclaimers